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Nitric oxide (NO) radicals generated by endothelial
nitric oxide synthase (eNOS) are involved in the reg-
ulation of vascular tone. In addition, NO radicals de-
rived from eNOS inhibit platelet aggregation and leu-
kocyte adhesion to the endothelium and, thus, may
have anti-inflammatory effects. To study the role of
eNOS in renal inflammation, the development of ac-
celerated anti-glomerular basement membrane (GBM)
glomerulonephritis was examined in mice lacking a
functional gene for eNOS and compared with wild-
type (WT) C57BL/B6j mice. WT C57BL/6j mice (n 5 12)
and eNOS knockout (2/2) mice (n 5 12) were immu-
nized intraperitoneally with sheep IgG (0.2 mg in
complete Freund’s adjuvant). At day 6.5 after immu-
nization, mice received a single i.v. injection of sheep
anti-mouse GBM (1 mg in 200 ml PBS). Mice were
sacrificed at day 1 and 10 after induction of the dis-
ease. All WT mice survived until day 10, whereas 1
eNOS2/2 mouse died and 2 more became moribund,
requiring sacrifice. At day 10, eNOS2/2 mice had
higher levels of blood urea nitrogen than WT mice
(P < 0.02), although proteinuria was comparable.
Immunofluorescence microscopy documented simi-
lar IgG deposition in both WT and eNOS2/2 mice, but
eNOS2/2 mice had more extensive glomerular stain-
ing for fibrin at day 10 (P < 0.007). At day 10, light
microscopy demonstrated that eNOS2/2 mice had
more severe glomerular thrombosis (P < 0.003) and
influx of neutrophils (P < 0.006), but similar degrees
of overall glomerular endocapillary hypercellularity
and crescent formation. In conclusion, accelerated
anti-GBM glomerulonephritis is severely aggravated
in eNOS2/2 mice, especially with respect to glomer-
ular capillary thrombosis and neutrophil infiltration.
These results indicate that NO radicals generated by
eNOS play a protective role during renal inflamma-
tion. (Am J Pathol 2000, 156:879–888)
The production of nitric oxide (NO) radicals has been
recognized as an important mediator system in various
physiological and pathophysiological processes. NO is
produced from the terminal guanidine nitrogen of L-argi-
nine by nitric oxide synthases (NOS). Three isoforms
have been identified encoded by distinct genes: neuro-
nal NOS (nNOS), endothelial NOS (eNOS), and inducible
NOS (iNOS).1 nNOS is expressed in neurons and plays a
role in neurotransmission. It is also found in the macula
densa of the kidney where it may be involved in the
regulation of the vascular tone of the afferent and efferent
arterioles.2 Expression of eNOS is found predominantly in
endothelial cells and plays a significant role in the regu-
lation of vascular tone. Additionally, NO generated by
eNOS has been shown to inhibit platelet aggregation and
platelet and leukocyte adhesion to the endothelium, and
thus may have anti-inflammatory effects.3,4 Both nNOS
and eNOS are calcium- and calmodulin-dependent, are
constitutively expressed, and generate small amounts
(measurable in pmol) of NO. In contrast, iNOS is a calci-
um- and calmodulin-independent enzyme expressed in a
variety of cell types, including intrinsic renal cells, only
after exposure to inflammatory stimuli. Once induced,
iNOS is capable of producing large amounts (measur-
able in mmol) of NO for prolonged periods of time.5
Increased NO production has been demonstrated in
several experimental models of glomerulonephritis, most
likely derived from infiltrating inflammatory cells express-
ing iNOS.6,7 Increased production of NO radicals can be
cytotoxic and cytostatic and may contribute to tissue
injury. The exact role of NO in glomerulonephritis, how-
ever, is controversial. Results from studies attempting to
inhibit excessive NO production in experimental models
of glomerulonephritis are inconclusive. Whereas some
studies have shown a beneficial effect of NOS inhibition
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on renal inflammation,8,9 detrimental effects have been
reported in others.10,11
In an experimental model of anti-myeloperoxidase-as-
sociated crescentic glomerulonephritis (CGN), we re-
cently investigated the temporal expression of NO syn-
thases in conjunction with platelet aggregation,
inflammatory cell influx, generation of reactive oxygen
species (ROS), and nitrotyrosine formation. These stud-
ies showed that eNOS expression was markedly de-
creased and, in the early stages, was associated with
extensive platelet aggregation. In addition, a marked
transient induction of iNOS in polymorphonuclear cells
and macrophages was observed coinciding with the
generation of ROS and formation of nitrotyrosines.12
These studies suggested that NO generated by eNOS
may be protective, whereas NO generated through iNOS
may be involved in tissue injury in this experimental
model of anti-myeloperoxidase-associated CGN. How-
ever, in a recent study, Cattell et al demonstrated that
accelerated anti-glomerular basement membrane (GBM)
glomerulonephritis in mice lacking iNOS is indistinguish-
able from that in wild-type (WT) mice, indicating that
iNOS does not play an essential role in this form of
glomerulonephritis in mice.13
The present study was designed to determine the role
of NO radicals generated by eNOS in the development of
murine accelerated anti-GBM glomerulonephritis. To this
end, the course of murine anti-GBM glomerulonephritis
was examined in mice homozygous for the disruption of
the eNOS gene and compared to that in WT mice.
Materials and Methods
Animals
eNOS-deficient mice were generated by homologous re-
combination as described previously.14 These mice were
backcrossed to C57BL/6j mice for 10 generations to ob-
tain congenic knockout mice. WT C57BL/6j mice (Jack-
son Laboratories, Bar Harbor, ME) were used as controls.
Tail DNA from each mouse was analyzed by PCR to
confirm the genotype for eNOS. All mice were bred and
maintained in a specific-pathogen-free facility and re-
ceived standard chow and water ad libitum.
Induction of Accelerated Anti-GBM
Glomerulonephritis
Mice were immunized by i.p. injection of 0.2 mg of sheep
IgG in complete Freund’s adjuvant (1:1 v/v, 200 ml total
volume). After 6.5 days, mice were intravenously injected
with 1 mg of sheep anti-mouse GBM IgG in phosphate
buffered saline (PBS; 200 ml total volume) prepared as
described previously.15 The endotoxin concentration in
the stock anti-GBM preparation was 45 pg/ml. No endo-
toxin (,0.5 pg/ml) could be detected in the diluted anti-
GBM preparation used for injection.
Albuminuria
One day after the sheep anti-GBM IgG injection and
before the day of sacrifice, mice were placed in individual
metabolic cages for the collection of urine. Urinary albu-
min content was measured with the mouse albumin en-
zyme-linked immunosorbent assay (ELISA) quantitation
kit (Bethyl Laboratories, Montgomery, TX) using purified
mouse albumin as a reference. Briefly, ELISA strips
(Costar, Cambridge, MA) were coated with affinity-puri-
fied goat anti-mouse albumin in 0.1 mol/L sodium car-
bonate buffer, pH 9.0. Next, plates were incubated with
serial dilutions of mouse urine in 1% goat serum in PBS/
0.05% Tween 20 followed by peroxidase-labeled goat
anti-mouse albumin. Binding was detected using tetra-
methyl benzidine (TMB, Sigma, St. Louis, MO) and the
reaction was stopped with 2 mol/L H2SO4. Plates were
analyzed at 450 nm and albumin concentrations were
determined from the standard curve and corrected for
urine volume.
Anti-Sheep IgG Response
Sera collected at the time of sacrifice were tested for the
presence of anti-sheep IgG antibodies by ELISA. Briefly,
ELISA strips (Costar) were coated with sheep IgG (20
mg/ml) in 0.1 mol/L sodium carbonate buffer, pH 9.0.
Next, strips were incubated with serial dilutions of the
mouse sera starting at a 1:50 dilution in 1% donkey serum
in PBS/0.05% Tween 20. Antibody binding was detected
with by donkey anti-mouse IgG (Jackson Laboratories)
followed by p-nitrophenyl phosphate substrate (Sigma).
The optical density was analyzed at 405 nm and a stan-
dard curve was prepared from a reference serum. Anti-
body concentrations were computed from the linearized
titration curve after log-logit transformation of the absor-
bances of the respective dilutions of the reference serum.
The antibody concentration of the reference serum was
arbitrarily set at 100 U.
Blood Urea Nitrogen Measurement
Blood urea nitrogen (BUN) was measured in sera col-
lected at the time of sacrifice by an enzymatic degrada-
tion assay on a Vitros 250 automated analyzer (Johnson
& Johnson, South Brunswick, NJ).
Light Microscopy
Renal tissue was fixed in 10% buffered formalin and
embedded in paraffin using standard procedures. Two-
micron sections were stained with periodic acid-Schiff
(PAS) and hematoxylin and eosin (H&E). Sections were
examined for glomerular hypercellularity, necrosis,
thrombosis, crescents, sclerosis, interstitial leukocyte in-
filtrates, and fibrosis. A glomerular crescent score for
each animal was determined by evaluating crescent for-
mation in 30 glomeruli per mouse. Only glomeruli that had
two or more layers of cells in Bowman’s space were
considered crescentic. In addition, the presence of PAS-
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positive material within the glomeruli was semiquantita-
tively scored in 50 glomeruli per mouse according to the
following scoring system: 0, absent; 1, up to one-third; 2,
one-third to two-thirds; 3, more than two-thirds of the total
glomerular area effaced by PAS-positive material. Re-
sults were expressed as mean scores per mouse.
Immunohistochemistry
Renal tissue was snap-frozen in isopentane and embed-
ded in Tissue-Tek (Sakura Finetek, Torrance, CA). To
determine the absence or presence of eNOS and iNOS
protein, renal tissue sections were fixed in acetone and
incubated with a rabbit polyclonal antibodies directed
against eNOS (Santa Cruz Biotechnology, Santa Cruz,
CA) or iNOS (Transduction Laboratories, Lexington, KY)
After incubation with the primary antibody, sections were
washed in PBS and endogenous peroxidase activity was
blocked by incubation with 0.05% H2O2/PBS for 20 min-
utes. Next, sections were incubated with peroxidase-
labeled goat anti-rabbit IgG followed by peroxidase-la-
beled rabbit anti-goat IgG (both from Dakopatts,
Glostrup, Denmark) both diluted in 5% normal mouse
serum in PBS. Binding was visualized using aminoethyl-
carbamizole (AEC, Sigma) and H2O2 as the substrate.
To characterize the leukocyte infiltrate, renal tissue
sections (4 mm) were fixed in acetone and incubated with
rat monoclonal antibodies directed against neutrophils
(NIMP-R14), monocytes/macrophages (FA-11), CD11b
(Pharmingen, San Diego, CA), and T cells (CD3, Pharm-
ingen). The staining procedure was similar to the one
described above using peroxidase-labeled rabbit anti-rat
IgG followed by peroxidase-labeled goat anti-rabbit IgG
(both from Dakopatts) both diluted in 5% normal mouse
serum in PBS as secondary antibodies. Glomerular infil-
trates were evaluated by counting the number of positive
cells within 30 glomeruli. Numbers represent positive
cells per glomerular cross section. Interstitial infiltrates
were quantified on a semiquantitative scale: 0, absent; 1,
minimal numbers; 2, few; 3, moderate numbers; 4, nu-
merous.
Immunofluorescence
Four-micron renal tissue sections were fixed in acetone.
The presence of sheep IgG, mouse IgG, and the depo-
sition of fibrinogen was analyzed using fluorescein iso-
thiocyanate-labeled rabbit anti-sheep IgG, rabbit anti-
mouse IgG, and rabbit anti-human fibrinogen (cross-
reactive with mouse; all from Dakopatts). The glomerular
presence of sheep IgG and mouse IgG was quantitated
by assessing the endpoint titer for detection of staining
using four dilutions for each antibody (1:200 to 1:1600 for
sheep IgG and 1:100 to 1:800 for mouse IgG). Fibrin
deposits were evaluated in 30 glomeruli per mouse ac-
cording to the following semiquantitative system: 0, no
fibrin deposits; 1, up to one-third; 2, one-third to two-
thirds; 3, more than two-thirds of the total glomerular area
staining positive for fibrin. Results were expressed as
mean scores per mouse.
Statistical Analysis
Results were analyzed for statistical differences by the
two-tailed Mann-Whitney U test. P # 0.05 was consid-
ered statistically significant. Values are presented as
mean 6 SD.
Experimental Design
Mice between 9 and 14 weeks of age were used in this
study. The following groups were studied: (i) C57BL/6J
WT mice, 1 day (n 5 5) and 10 days (n 5 7) after
induction of accelerated anti-GBM glomerulonephritis; (ii)
eNOS2/2 mice, 1 day (n 5 5) and 10 days (n 5 7) after
induction of accelerated anti-GBM glomerulonephritis
(from the one mouse that died at day 6 after induction of
accelerated anti-GBM glomerulonephritis, only tissue for
light microscopy was obtained); and normal WT (n 5 4)
and eNOS2/2 (n 5 3) mice.
Results
Circulating Mouse Anti-Sheep IgG Antibody
Both WT and eNOS2/2 mice immunized with sheep IgG
in complete Freund’s adjuvant developed antibodies
against sheep IgG as measured by ELISA. No significant
difference was found in the anti-sheep IgG titer between
the two groups (arbitrary units: 252.5 6 80.4 vs. 227.14 6
84.9 at day 10 in eNOS2/2 and WT mice, respectively).
Sera from normal nonimmunized WT and eNOS2/2 mice
were negative.
Expression of eNOS and iNOS
Immunohistochemistry for eNOS in untreated eNOS2/2
mice confirmed the absence of eNOS protein (Figure 1A).
In untreated WT mice, strong immunoreactivity for eNOS
was found in interstitial vessels and glomerular and tubu-
lar capillaries (Figure 1B). At day 1 and 10 after induction
of anti-GBM nephritis, a decrease or absence in glomer-
ular eNOS expression was observed, which in most glo-
meruli was focal and segmental (Figure 1, C-E). At these
time points, strong expression of eNOS could still be
observed in cortical vessels (Figure 1, C and E). By
immunohistochemistry, no difference in iNOS expression
was detected between WT and eNOS2/2 mice. In all
mice, weak immunoreactivity for iNOS was found in tu-
bular epithelial cells and vascular smooth muscle cells. In
addition, only occasional iNOS positive cells were de-
tected in interstitium and glomeruli of all mice.
Histological Features of Glomerulonephritis in
WT and eNOS2/2 Mice
By light microscopy, renal morphology in normal
eNOS2/2 mice was indistinguishable from that in normal
WT mice (Figure 2, A and B).
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Preimmunized C57BL/6J WT mice developed a prolif-
erative and crescentic glomerulonephritis after adminis-
tration of sheep anti-mouse GBM antibody. In the early
phase (day 1), renal injury was characterized by a mild
influx of PMN and mild focal segmental glomerular throm-
bus formation (Figure 2, C and E). All mice survived until
day 10. At this time point, a proliferative glomerulonephri-
tis had developed with crescent formation in 17 6 5% of
glomeruli and focal interstitial infiltrates of leukocytes
(Figure 3, A and B). Deposits of PAS-positive material in
the glomerular tufts, consistent with capillary thrombosis,
were focal and mild, affecting 6 to 20% (mean, 11.3 6
5.5%) of the glomeruli (Figure 3, A and B).
In eNOS2/2 mice, the development of glomerulone-
phritis was severely aggravated, especially the develop-
ment of thrombosis and necrosis. One mouse died at day
Figure 1. Immunohistochemistry for eNOS in renal tissue from WT and
eNOS2/2 mice. A: No eNOS immunoreactivity was found in eNOS2/2 mice
(G indicates a glomerulus). B: In WT mice, strong immunoreactivity was found
in arteries (inset), arterioles (arrows) and glomerular and peritubular capil-
laries. C2E: A focal and segmental decrease or loss (D, arrows) in glomerular
eNOS expression was detected at days 1 and 10 after induction of accelerated
anti-GBM glomerulonephritis. At these time points, strong expression of eNOS
in cortical arteries could still be detected (C, inset; E, arrow). Original
magnifications, 3250 (A2C), 3400 (D and insets), 3200 (E).
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6 after induction of the disease and two additional mice
became moribund at day 8 and 9, respectively, and were
sacrificed. All these mice had severe ascites. By light
microscopy, at day 1, a mild influx of neutrophils was
observed. In addition, glomerular thrombus formation
was observed that was more extensive than in WT mice,
reflected by a significantly higher score for glomerular
deposits of PAS-positive material (Figure 2, D and F, and
Figure 4). In some glomeruli all glomerular capillaries
showed thrombus formation. Severe glomerular injury de-
veloped by day 10, characterized particularly by depos-
its of PAS-positive material in 60 to 78% (mean, 70.5 6
Figure 2. Light microscopy of renal tissue from normal WT (A) and eNOS2/2 (B) mice and at day 1 after administration of sheep anti-mouse GBM Ig. Focal and
segmental glomerular thrombosis was observed in WT mice (C and E, PAS stain). More extensive glomerular thrombosis was found in eNOS2/2 mice (D and
F, PAS stain). Original magnifications, 3200 (A-D), 3400 (E and F).
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Figure 3. Light microscopy of renal tissue 10 days after administration of sheep anti-mouse GBM Ig in WT (A, B, PAS stain) and eNOS2/2 mice (C-F, PAS stain).
A: Overview of renal tissue in a WT mouse demonstrating mild glomerular hypercellularity and glomerular crescent formation. B: Glomerulus from a WT mouse
showing crescent formation and mild periglomerular inflammatory cell accumulation. C: Overview of renal tissue from an eNOS2/2 mouse that became
moribund and was sacrificed at day 8 after sheep anti-mouse GBM Ig administration. Glomerular deposits of PAS positive material are prominent in all glomeruli.
D: Glomerulus from the same mouse as in C showing extensive capillary thrombosis and necrosis. E: Overview of renal tissue from an eNOS2/2 mouse at 10
days after administration of sheep anti-mouse GBM Ig. Glomeruli show extensive deposits of PAS-positive material. F: Glomerulus from the same mouse as in
E showing deposits of PAS-positive material throughout the glomerulus, segmental karyorrhexis, and the development of a small crescent (top right). Original
magnifications, 3200 (A, C, E) and 3400 (B, D, F).
884 Heeringa et al
AJP March 2000, Vol. 156, No. 3
8.2%) of glomeruli (Figure 3, E and F). In the mice that
died or became moribund, deposits of PAS-positive ma-
terial were even more extensive, affecting more than 90%
of glomeruli (mean, 94.7 6 2.3%; Figure 3, C and D).
Also, as revealed by semiquantitative analysis, the
amount of PAS-positive material per glomerulus was sig-
nificantly higher in the eNOS2/2 mice compared with WT
mice (Figure 4). In the eNOS2/2 mice, small crescents
developed in 13 6 4% of glomeruli, which was not sig-
nificantly different from that in WT mice.
Immunofluorescence
By immunofluorescence, strong linear glomerular depo-
sition for sheep IgG was found in both WT and eNOS2/2
mice at days 1 and 10 after administration of sheep
anti-mouse GBM IgG (Figure 5, A and B). The median
endpoint titer for detection was 1:1600 in both groups.
Also, a prominent granular-to-linear staining was ob-
served for mouse IgG at both time points in WT and
eNOS2/2 mice (median endpoint titer 1:400 in both
groups). At day 1 after administration of sheep anti-
mouse GBM, glomerular fibrin deposition was mild in
both WT and eNOS2/2 mice. However, at 10 days, a
marked increase in fibrin deposition, indicative of exten-
sive thrombosis, was found in eNOS2/2 mice compared
Figure 4. Semiquantitation of glomerular deposits of PAS-positive material as
a measure of glomerular injury. Deposits of PAS-positive material in glomer-
uli was quantitated in WT and eNOS2/2 mice at the indicated time points
according to the following scoring system: 0, absent; 1, up to one-third of
glomerulus involved; 2, one-third to two-thirds involved; 3, more than two-
thirds involved. Fifty glomeruli per mouse were evaluated. Bars represent
means 6 SD.
Figure 5. Immunofluorescence microscopy for mouse IgG and fibrinogen 10 days after administration of sheep anti-mouse GBM Ig in WT (A and C) and
eNOS2/2 (B and D) mice. A: Linear staining for mouse IgG along the glomerular capillary wall in a WT mouse. B: Linear staining for mouse IgG along the
glomerular capillary wall in an eNOS2/2 mouse. C: Glomerulus from a WT mouse showing segmental fibrin deposition. D: Glomerulus from an eNOS2/2
mouse showing extensive global fibrin deposition. Original magnifications, 3400.
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to WT (fibrin score 1.93 6 0.18 vs. 0.91 6 0.26, P #
0.006) (Figure 5, C and D, and Figure 6)
Characterization of Leukocyte Infiltrate
In WT mice, a mild glomerular influx of PMNs and CD11b-
positive cells was found at day 1 (Figure 7). At 10 days,
the number of glomerular CD11b-positive cells increased
and a mild influx of FA/11-positive and T cells was ob-
served (Figure 7). At this time point, the number of intra-
glomerular PMNs had slightly decreased. In eNOS2/2
mice, similar results were found for CD11b-positive cells,
FA/11-positive cells, and T cells. However, glomerular
influx of PMNs at day 10 was significantly higher com-
pared to WT mice (1.3 6 0.12 vs. 0.77 6 0.11, P # 0.006;
normal, 0.18 6 0.08; Figure 7). In the mice that became
moribund, the glomerular PMN infiltrates were even more
prominent, averaging 3.2 and 2.0 PMNs per glomerular
cross-section.
BUN and Albuminuria
BUN levels in normal WT and eNOS2/2 mice were ,20
mg/dl. In WT mice a slight increase in BUN levels was
detected at day 10 (Figure 8A). At this time point,
eNOS2/2 mice developed severe renal impairment with
markedly increased BUN levels (105.0 6 31.0 mg/dl vs.
47.0 6 21.0 mg/dl, P # 0.01; Figure 8A). In the two
eNOS2/2 mice that became moribund, BUN levels were
166.0 mg/dl and 150.0 mg/dl.
Albuminuria was detectable at day 1, increased at day
2, and remained elevated until day 10 (Figure 8B; albu-
minuria in normal WT (n 5 4) and eNOS2/2 mice (n 5 3)
was ,50 mg/18 hours). However, no significant differ-
ences were found between eNOS2/2 and WT mice at
any time point.
Figure 6. Semiquantitation of glomerular fibrin deposition in WT and
eNOS2/2 mice. Fibrin deposition was evaluated in 30 glomeruli per mouse
according to the following scoring system: 0, no fibrin deposits; 1, up to
one-third of glomerulus involved; 2, one-third to two-thirds involved; 3, more
than two-thirds involved. Bars represent mean 6 SD.
Figure 7. Quantitation of glomerular numbers of PMNs (A), CD11b-positive cells (B), FA/11-positive cells (C), and CD3-positive T cells (D) in WT and eNOS2/2
mice during the course of accelerated anti-GBM glomerulonephritis. Glomerular infiltrates were evaluated by counting the number of positive cells within 30
glomeruli. Bars represent mean numbers per glomerular cross-section (gcs) 6 SD
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Discussion
To determine the role of NO radicals produced by con-
stitutively expressed eNOS in renal inflammation, we
studied the course of a well characterized model of ac-
celerated anti-GBM glomerulonephritis in mice lacking
eNOS protein (eNOS2/2). Compared to WT mice, the
development of glomerulonephritis was severely aggra-
vated in eNOS2/2 mice illustrated by increased mortality
and morbidity. Pathologically, extensive glomerular cap-
illary thrombosis and fibrin deposits were observed af-
fecting more than 50% of glomeruli in all eNOS2/2 mice
by day 10. In addition, BUN levels were markedly in-
creased indicating the development of severe renal im-
pairment in these mice.
Over the past few years, studies have pointed to a
complex role of NO in renal inflammation.6 Increased
production of NO radicals has been demonstrated in
several experimental models of glomerulonephritis.6 In
most, if not all, cases the increased generation of NO
radicals has been attributed to the induction of iNOS in
infiltrating inflammatory cells or intrinsic renal cells such
as mesangial cells. In these models of glomerulonephri-
tis, iNOS mRNA can be detected in glomeruli by ribonu-
clease protection assays and reverse transcription PCR,
and iNOS protein by immunohistochemistry. Increased
production of NO radicals can contribute to renal injury
through direct cytotoxic actions. In addition, NO radicals
can react with superoxide radicals generating the highly
reactive compound peroxynitrite.16 Peroxynitrite has
been shown to initiate lipid peroxidation and induces
nitration of tyrosine residues, leading to loss of protein
structure and function.16
To further define the role of increased NO production in
renal inflammation, several studies have attempted to
decrease excessive NO production either by using inhib-
itors of NO synthases or by depletion of circulating argi-
nine. In some of these studies, inhibition of NO produc-
tion has been shown to augment glomerulonephritis,
implicating a toxic role for NO radicals.8,9,17 In other
studies, however, blockade of NO production aggra-
vated renal injury, pointing to a protective role of NO
radicals.10,11 Until recently, the major NOS inhibitors
lacked NOS isoform specificity, which may explain part of
the conflicting data. Overall, these studies have indicated
that increased NO production during renal inflammation
may have detrimental or protective effects, which proba-
bly depends on the NOS isoform generating NO radicals,
the amount of NO radicals produced, and the simulta-
neous production of ROS. The present study clearly dem-
onstrates that inactivation of eNOS by disruption of the
eNOS gene exacerbates renal injury in the accelerated
anti-GBM glomerulonephritis model. As such, these re-
sults provide direct evidence for a protective role of
eNOS derived NO radicals in renal inflammation.
The exact mechanisms by which lack of eNOS-derived
NO radicals exacerbates renal injury in this model are not
clear, but several possibilities may be considered.
Mice lacking a functional gene for eNOS were origi-
nally generated to study the involvement of NO radicals
produced by eNOS in blood pressure regulation.14,18
These studies showed that eNOS2/2 mice were indis-
tinguishable from WT mice in general appearance and
histology, but had significantly increased blood pres-
sures associated with a twofold increase in plasma renin
activities.14 Also, long term treatment with the nonselec-
tive NOS inhibitors L-NAME or L-NNA in rats causes
hypertension and leads to proteinuria and renal morpho-
logical changes, such as capillary collapse and tubulo-
interstitial injury.19,20 In addition, hypertension is a factor
known to exacerbate glomerulonephritis in rats.21 Thus,
the increased blood pressures in eNOS2/2 mice may
have contributed to the increased renal injury after induc-
tion of accelerated anti-GBM glomerulonephritis we ob-
served; this possibility warrants further investigation.
In vitro studies have also demonstrated that endothelial
cell-derived NO radicals inhibit platelet aggregation and
platelet and leukocyte adhesion to the endothelium.3 In
vivo, administration of the nonselective NOS inhibitor L-
NAME in models of endotoxemia exacerbates liver and
kidney injury associated with increased thrombosis and
leukocyte infiltration, especially PMNs.11,22,23 Part of
these effects have been attributed to increased adhesion
molecule expression (ICAM-1, P-selectin) by the endo-
thelium after inhibition of endogenous NO production
most likely derived from eNOS.22–24 In the present study,
glomerular capillary thrombosis was a prominent feature
of the disease in eNOS2/2 mice. In addition, a small but
significant increase in glomerular PMN influx was ob-
served in the eNOS2/2 mice at day 10.
In conclusion, the course of accelerated anti-GBM glo-
merulonephritis is severely aggravated in mice lacking
Figure 8. Blood urea nitrogen (BUN) levels (A) and the development of
albuminuria (B) after the induction of accelerated anti-GBM glomerulone-
phritis in WT and eNOS2/2 mice. Bars represent mean 6 SD.
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NO production by eNOS. These results point to a protec-
tive role of eNOS-derived NO production in glomerulone-
phritis and emphasize its importance in maintaining the
antithrombogenic and anti-inflammatory properties of the
endothelium.
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